
Emyria
Emyria operates a network of specialist medical clinics focused on collecting and commercializing clinical data. The company leverages proprietary software to gather anonymized patient data, which is then used to generate clinical evidence. This positions Emyria uniquely in the healthcare sector, combining medical services with data-driven insights.
Short position
Emyria (ASX:EMD) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 6,369 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.10% in February 2020. EMD is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Emyria (EMD) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $4.1MM (source: ASX (Markit))vs $1.4MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 29 Sep 2026
- NPAT
- −$6.1MM (source: ASX (Markit))vs −$3.1MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 29 Sep 2026
- EPS (diluted)
- −$0.008T (source: Derived: trailing 12 months at year end)vs −$0.007 (FY25)
- Derived: trailing 12 months at year end, as at 29 Sep 2026
- Rev YoY
- +190.6%FY
- EPS YoY
- n/aTTM
- ASX (Markit)
- Derived: trailing 12 months at year end
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 9 Oct 2026
- Gross margin
- n/a
- Operating margin
- n/a
- Net margin
- −150.8%
- FCF margin
- n/a
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Source: ASX (Markit), as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $4.1MM (source: ASX (Markit)) | $1.4MM (source: ASX (Markit)) | $2.2M | $1.6M |
| Gross profit | n/a | n/a | −$167.5K | −$647.5K |
| Operating income | n/a | n/a | −$6.9M | −$7.1M |
| EBITDA | n/a | n/a | −$10.5M | −$4.6M |
| EBIT | n/a | n/a | −$11.2M | −$5.0M |
| Interest expense | n/a | n/a | $253.3K | $128.8K |
| Pretax income | n/a | n/a | −$11.5M | −$5.1M |
| Tax | n/a | n/a | $0 | $0 |
| NPAT | −$6.1MM (source: ASX (Markit)) | −$3.1MM (source: ASX (Markit)) | −$11.5M | −$5.1M |
| Net interest income | n/a | n/a | −$231.7K | −$98.5K |
| EPS basic | −$0.008T (source: Derived: trailing 12 months at year end) | −$0.007 | −$0.032 | −$0.018 |
| EPS diluted | −$0.008T (source: Derived: trailing 12 months at year end) | −$0.007 | −$0.032 | −$0.018 |
| Shares | n/a | n/a | 409.0M | 310.6M |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- Annual ReportAnnual Report9 Oct 2026via asx_announcements
- Appendix 4E & Annual Financial Report Year End 30 June 2026Annual Results31 Aug 2026via asx_announcements
- June 2026 Quarterly Activities Report and Appendix 4CQuarterly Report29 Jul 2026via asx_announcements
- March 2026 Quarterly Activities Report and Appendix 4CQuarterly Report28 Apr 2026via asx_announcements
- Appendix 4D and Half Year End Financial ReportHalf Year Results26 Feb 2026via asx_announcements
- Record Half-Year Performance and National ExpansionHalf Year Results26 Feb 2026via asx_announcements
- December 2025 Quarterly Activities Report and Appendix 4CQuarterly Report28 Jan 2026via asx_announcements
- September 2025 Quarterly Activities Report and Appendix 4CQuarterly Report27 Oct 2025via asx_announcements
- Annual ReportAnnual Report10 Oct 2025via asx_announcements
- Appendix 4E & Annual Report for the Year Ended 30 June 2025Annual Results28 Aug 2025via asx_announcements
Showing 10 of 70 reports